Who invested in NewLeaf Symbiotics?
NewLeaf Symbiotics's investors include RockPort Capital, Open Prairie, Pangaea Ventures, Monsanto Growth Ventures and Pangaea, and 6 more on record.

United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$123Mraised across 5 rounds since 2013, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $24M sold, first sale Jun 2017
Reported by FinSMEsSEC filing: $24M sold, first sale Jun 2017
From a historical funding recordSEC filing: $17M sold, first sale Sept 2014
Reported by finance.yahoo.comSEC filing: $1.2M sold, first sale Nov 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
NewLeaf Symbiotics's investors include RockPort Capital, Open Prairie, Pangaea Ventures, Monsanto Growth Ventures and Pangaea, and 6 more on record.
NewLeaf Symbiotics has raised $123M across 5 rounds since 2013.
NewLeaf Symbiotics's most recent round was a Series D of $45M in Dec 2023.
Its most recent round, $45M in Dec 2023, is also its largest on record.
NewLeaf Symbiotics's first round on record, in Jan 2013, was backed by RockPort Capital, Pangaea Ventures and Open Prairie.
NewLeaf Symbiotics's latest named round is a Series D, in Dec 2023.
NewLeaf Symbiotics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.